» Articles » PMID: 38188703

Therapeutic Supramolecular Polymers: Designs and Applications

Overview
Journal Prog Polym Sci
Publisher Elsevier
Date 2024 Jan 8
PMID 38188703
Authors
Affiliations
Soon will be listed here.
Abstract

The self-assembly of low-molecular-weight building motifs into supramolecular polymers has unlocked a new realm of materials with distinct properties and tremendous potential for advancing medical practices. Leveraging the reversible and dynamic nature of non-covalent interactions, these supramolecular polymers exhibit inherent responsiveness to their microenvironment, physiological cues, and biomolecular signals, making them uniquely suited for diverse biomedical applications. In this review, we intend to explore the principles of design, synthesis methodologies, and strategic developments that underlie the creation of supramolecular polymers as carriers for therapeutics, contributing to the treatment and prevention of a spectrum of human diseases. We delve into the principles underlying monomer design, emphasizing the pivotal role of non-covalent interactions, directionality, and reversibility. Moreover, we explore the intricate balance between thermodynamics and kinetics in supramolecular polymerization, illuminating strategies for achieving controlled sizes and distributions. Categorically, we examine their exciting biomedical applications: individual polymers as discrete carriers for therapeutics, delving into their interactions with cells, and dynamics; and supramolecular polymeric hydrogels as injectable depots, with a focus on their roles in cancer immunotherapy, sustained drug release, and regenerative medicine. As the field continues to burgeon, harnessing the unique attributes of therapeutic supramolecular polymers holds the promise of transformative impacts across the biomedical landscape.

References
1.
Feng Q, Wei K, Lin S, Xu Z, Sun Y, Shi P . Mechanically resilient, injectable, and bioadhesive supramolecular gelatin hydrogels crosslinked by weak host-guest interactions assist cell infiltration and in situ tissue regeneration. Biomaterials. 2016; 101:217-28. DOI: 10.1016/j.biomaterials.2016.05.043. View

2.
MacKay J, Chen M, McDaniel J, Liu W, Simnick A, Chilkoti A . Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater. 2009; 8(12):993-9. PMC: 2862348. DOI: 10.1038/nmat2569. View

3.
Alvarez Z, Kolberg-Edelbrock A, Sasselli I, Ortega J, Qiu R, Syrgiannis Z . Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury. Science. 2021; 374(6569):848-856. PMC: 8723833. DOI: 10.1126/science.abh3602. View

4.
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65(1-2):271-84. DOI: 10.1016/s0168-3659(99)00248-5. View

5.
Black M, Trent A, Kostenko Y, Lee J, Olive C, Tirrell M . Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo. Adv Mater. 2012; 24(28):3845-9. DOI: 10.1002/adma.201200209. View